Na Lin

5.0k total citations
167 papers, 3.6k citations indexed

About

Na Lin is a scholar working on Molecular Biology, Complementary and alternative medicine and Rheumatology. According to data from OpenAlex, Na Lin has authored 167 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 43 papers in Complementary and alternative medicine and 31 papers in Rheumatology. Recurrent topics in Na Lin's work include Natural Compounds in Disease Treatment (31 papers), Rheumatoid Arthritis Research and Therapies (26 papers) and Pharmacological Effects of Natural Compounds (22 papers). Na Lin is often cited by papers focused on Natural Compounds in Disease Treatment (31 papers), Rheumatoid Arthritis Research and Therapies (26 papers) and Pharmacological Effects of Natural Compounds (22 papers). Na Lin collaborates with scholars based in China, United States and Japan. Na Lin's co-authors include Yanqiong Zhang, Chunfang Liu, Xiangying Kong, Akira Itô, Xia Mao, Qiuyan Guo, Takashi Sato, Weiheng Chen, Ying Xu and Xiaoyue Wang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Na Lin

157 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Na Lin 1.7k 795 671 524 410 167 3.6k
Yufeng Xia 1.8k 1.0× 634 0.8× 629 0.9× 285 0.5× 395 1.0× 162 4.1k
Qing Zhang 2.1k 1.2× 390 0.5× 499 0.7× 235 0.4× 467 1.1× 135 4.5k
Qiang Meng 1.9k 1.1× 285 0.4× 974 1.5× 115 0.2× 382 0.9× 185 4.7k
Zhifeng Wei 1.5k 0.9× 277 0.3× 483 0.7× 214 0.4× 376 0.9× 131 3.0k
Dongwoo Nam 1.3k 0.8× 413 0.5× 394 0.6× 60 0.1× 343 0.8× 101 2.7k
Yih‐Shou Hsieh 1.8k 1.0× 281 0.4× 336 0.5× 167 0.3× 794 1.9× 124 4.1k
Gang Cao 2.0k 1.1× 496 0.6× 480 0.7× 111 0.2× 304 0.7× 145 4.2k
Mei Liu 1.2k 0.7× 210 0.3× 226 0.3× 214 0.4× 286 0.7× 129 3.1k
Xianglu Rong 1.5k 0.9× 249 0.3× 438 0.7× 88 0.2× 188 0.5× 76 3.2k

Countries citing papers authored by Na Lin

Since Specialization
Citations

This map shows the geographic impact of Na Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Lin more than expected).

Fields of papers citing papers by Na Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Lin. The network helps show where Na Lin may publish in the future.

Co-authorship network of co-authors of Na Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Na Lin. A scholar is included among the top collaborators of Na Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Lin. Na Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Tingting, et al.. (2025). The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy. International Journal of Biological Sciences. 21(6). 2462–2475.
2.
Zhou, Jun, Xuehui Wang, Xu Feng, et al.. (2025). Comorbidity profiles and treatment patterns of osteoarthritis patients in Beijing: A cross-sectional study based on community medical records. SHILAP Revista de lepidopterología. 2(2). 100061–100061.
3.
Li, Jinmiao, Na Lin, Yun Zhang, et al.. (2024). Ectoine protects corneal epithelial survival and barrier from hyperosmotic stress by promoting anti-inflammatory cytokine IL-37. The Ocular Surface. 32. 182–191. 8 indexed citations
4.
Xie, Yingxi, et al.. (2024). Cost-Effective Tunable Iontronic Pressure Sensors Based on a Performance Prediction Model. IEEE Sensors Journal. 24(20). 31796–31805. 2 indexed citations
5.
Zhang, Chu, Mingzhu Xu, Tao Li, et al.. (2024). Yu-Xue-Bi capsule ameliorates aggressive synovitis and joint damage in rheumatoid arthritis via modulating the SUCNR1/HIF-1α/TRPV1 axis. Phytomedicine. 136. 156354–156354. 1 indexed citations
6.
Li, Debao, et al.. (2024). Windfarm construction alters soil multinutrient cycling by destabilizing microfauna community in a mountain ecosystem. Journal of Environmental Management. 373. 123758–123758. 1 indexed citations
7.
Ding, Zihe, Xiaoyue Wang, Yi Zhang, et al.. (2024). Altered Iron-Mediated Metabolic Homeostasis Governs the Efficacy and Toxicity of Tripterygium Glycosides Tablets Against Rheumatoid Arthritis. Engineering. 39. 166–179. 7 indexed citations
8.
Ge, Xinyu, Zhaochen Ma, Wenjing Wei, et al.. (2024). Integrated proteomic and metabolomic analysis reveals the potential therapeutic mechanism of Quanduzhong capsule in rats with spontaneous hypertension and knee osteoarthritis. Journal of Ethnopharmacology. 340. 119176–119176. 2 indexed citations
9.
10.
Yang, Zhigang, Ping Dong, Na Lin, et al.. (2023). NOVA1 prevents overactivation of the unfolded protein response and facilitates chromatin access during human white adipogenesis. Nucleic Acids Research. 51(13). 6981–6998. 4 indexed citations
11.
Wang, Xiaoyue, Yi Zhang, Yi Zhang, et al.. (2023). Cross-talk between the RAS-ERK and mTOR signalings-associated autophagy contributes to tripterygium glycosides tablet-induced liver injury. Biomedicine & Pharmacotherapy. 160. 114325–114325. 10 indexed citations
12.
Zhang, Yi, Yi Zhang, Xiaoyue Wang, et al.. (2023). Enhanced efficacy with reduced toxicity of tripterygium glycoside tablet by compatibility with total glucosides of paeony for rheumatoid arthritis therapy. Biomedicine & Pharmacotherapy. 166. 115417–115417. 6 indexed citations
13.
Dong, Yawei, et al.. (2023). Topical Chinese patent medicines for chronic musculoskeletal pain: systematic review and trial sequential analysis. BMC Musculoskeletal Disorders. 24(1). 985–985.
14.
Zhang, Yanqiong, Xiaoyue Wang, Weijie Li, et al.. (2020). Inferences of individual differences in response to tripterysium glycosides across patients with Rheumatoid arthritis using a novel ceRNA regulatory axis. SHILAP Revista de lepidopterología. 10(6). e185–e185. 19 indexed citations
15.
Liu, Chunfang, Jingxia Wang, Qianqian Wang, et al.. (2020). Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. Journal of Ethnopharmacology. 260. 113039–113039. 96 indexed citations
16.
Liu, Haiying, et al.. (2020). Clinical efficacy of Duyiwei capsule in treating gingivitis. Medicine. 99(29). e20542–e20542. 1 indexed citations
17.
Bradley, Kailyn, et al.. (2017). A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls. Journal of Affective Disorders. 227. 752–758. 25 indexed citations
18.
Yao, Qi, Zifeng Pi, Shu Liu, et al.. (2014). A metabonomic study of adjuvant-induced arthritis in rats using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Molecular BioSystems. 10(10). 2617–2625. 27 indexed citations
19.
20.
Zhang, Yanqiong, Danhua Wang, Shufang Tan, et al.. (2013). A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Wu Tou Tang Acting on Rheumatoid Arthritis by Integrating Network Analysis. Evidence-based Complementary and Alternative Medicine. 2013. 1–12. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufeng Xia Breakdown of academic impact, for papers by Qing Zhang Breakdown of academic impact, for papers by Qiang Meng Breakdown of academic impact, for papers by Zhifeng Wei Breakdown of academic impact, for papers by Dongwoo Nam Breakdown of academic impact, for papers by Yih‐Shou Hsieh Breakdown of academic impact, for papers by Gang Cao Breakdown of academic impact, for papers by Mei Liu Breakdown of academic impact, for papers by Xianglu Rong
Rankless by CCL
2026